Catestatin: Antimicrobial Functions and Potential Therapeutics.

Area of Science:

• Microbiology
• Biochemistry
• Pharmacology

Background:

• Rising antimicrobial resistance presents a global health crisis, necessitating novel therapeutic strategies.
• Antimicrobial peptides (AMPs) are a promising class of compounds due to their evolutionary conserved mechanisms against bacterial resistance.
• Catestatin (CST), a peptide derived from Chromogranin A, has demonstrated diverse biological activities.

Purpose of the Study:

• To review the antimicrobial properties of Catestatin (CST) and its variants, including bCST1-15 and D-bCST1-15.
• To explore the potential of CST and its derivatives as therapeutic agents against antibiotic-resistant 'superbugs'.
• To examine the evolutionary conservation and safety profile of CST-based compounds.

Main Methods:

• Literature review of studies investigating CST and its derivatives.
• Analysis of antimicrobial, antifungal, and antiyeast activities.
• Evaluation of hemolytic effects and potential for inducing bacterial resistance.
• Assessment of synergistic effects with conventional antibiotics.

Main Results:

• CST, bCST1-15 (cateslytin), and particularly D-bCST1-15 exhibit significant antimicrobial effects against various bacterial strains.
• D-bCST1-15 demonstrates potent activity without inducing bacterial resistance or cytokine release.
• D-bCST1-15 enhances the efficacy of existing antibiotics like cefotaxime, amoxicillin, and methicillin.
• Human variants of CST and evolutionary conservation in mammals suggest broad applicability.

Conclusions:

• CST and its D-amino acid variant D-bCST1-15 are potent antimicrobial agents with a favorable safety profile.
• These peptides represent a promising therapeutic avenue for combating multidrug-resistant infections.
• Further research into CST-based therapies could address the critical challenge of antibiotic resistance.